Search

Author/Creator Offer, Steven M.

1. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update. Issue 2 (20th November 2017)

Authors:
Amstutz, Ursula; Henricks, Linda M.; Offer, Steven M.; Barbarino, Julia; Schellens, Jan H.M.; Swen, Jesse J.; Klein, Teri E.; McLeod, Howard L.; Caudle, Kelly E.; Diasio, Robert B.; Schwab, Matthias
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 103:Issue 2(2018)
Page Start:
210
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Haplotype structure defines effects of common DPYD variants c.85T > C (rs1801265) and c.496A > G (rs2297595) on dihydropyrimidine dehydrogenase activity: Implication for 5‐fluorouracil toxicity. Issue 8 (30th March 2021)

Authors:
Hamzic, Seid; Schärer, Dominic; Offer, Steven M.; Meulendijks, Didier; Nakas, Christos; Diasio, Robert B.; Fontana, Stefano; Wehrli, Marc; Schürch, Stefan; Amstutz, Ursula; Largiadèr, Carlo R.
Journal:
British journal of clinical pharmacology
Issue:
Volume 87:Issue 8(2021)
Page Start:
3234
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗